Jeroen H. A. Creemers

Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer

Harm Westdorp, Jeroen H. A. Creemers, Inge M. van Oort et al. · Journal for ImmunoTherapy of Cancer · 2019 · 113 citations · Full text

Medicine, Immunology, Oncology +17

Favorable overall survival in stage III melanoma patients after adjuvant dendritic cell vaccination

Kalijn F. Bol, Erik H.J.G. Aarntzen, Florentien E. M. in ’t Hout et al. · OncoImmunology · 2015 · 70 citations · Full text

Medicine, Immunology, Oncology +17

Assessing the safety, tolerability and efficacy of PLGA-based immunomodulatory nanoparticles in patients with advanced NY-ESO-1-positive cancers: a first-in-human phase I open-label dose-escalation study protocol

Jeroen H. A. Creemers, Inka Pawlitzky, Konstantina Grosios et al. · BMJ Open · 2021 · 46 citations · Full text

Medicine, Oncology, Pharmacology +17

Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trial

Kalijn F. Bol, Gerty Schreibelt, Martine Bloemendal et al. · Nature Communications · 2024 · 42 citations · Full text

Medicine, Immunology, Oncology +17

Tumor microenvironment shows an immunological abscopal effect in patients with NSCLC treated with pembrolizumab-radiotherapy combination

Lieke L. van der Woude, Mark A.J. Gorris, Inge M. N. Wortel et al. · Journal for ImmunoTherapy of Cancer · 2022 · 39 citations · Full text

Medicine, Immunology, Oncology +17